Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology

Fig. 5

GO and KEGG analysis for the potential targets of BSYQ decoction for asthma and IPF therapy by DAVID 6.8. A and B the top 30 enriched KEGG pathways of the 56 potential targets. C the top 15 enriched GO items, including biology process (BP), cellular compartment (CC), and molecular function (MF)

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us